Genes & biomarkers

EGFR variants

EGFR · exon 19 / L858R / exon 20

In lung cancer, the precise EGFR alteration matters.

Sources checked · Introductory guide

On this page

What does this result mean?

EGFR is a receptor for growth signals. In non-small cell lung cancer, changes such as exon 19 deletions or exon 21 variants can keep it active.[1]

How does it connect to treatment?

EGFR inhibitors such as osimertinib are used for selected EGFR-altered non-small cell lung cancers. Eligibility differs after surgery, after certain chemoradiation and in metastatic disease.[2]

What should I check in my report?

Distinguish exon 19 deletion, L858R and exon 20 insertion. If a new finding appears during treatment, ask how it relates to the original variant and possible resistance.

Questions for your care team

  • What is my exact EGFR variant and which drug criteria does it meet?
  • Which treatments or trials fit my cancer type, stage and previous treatment?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. MedlinePlus Genetics · EGFR (opens in a new tab)
  2. NCI · osimertinib (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

EGFR variants | Cancer Encyclopedia | My Chemo Diary